Pharmacy News

Hikal inks 10-year multi-product deal with global pharma co for APIs, Health News, ET HealthWorld

Life sciences firm Hikal Ltd on Wednesday said it has signed a 10-year deal with a global pharmaceutical company for development and supply of a portfolio of niche Active Pharmaceutical Ingredients (APIs). The company has signed a multi-year contract with a leading global pharmaceutical company.

This contract entails the development and supply of a portfolio of niche APIs over a period of 10 years, Hikal said in a regulatory filing.

The company did not reveal the name of the global pharmaceutical firm and the value of the deal.

Hikal said the company and its customer will partner to set up a manufacturing facility to maintain security of supplies for the next 10 years.

Both the companies will jointly invest at its Panoli site in Gujarat to set up a multi-purpose manufacturing asset for manufacturing of these APIs.

Commercial supplies will commence post successful development and plant commercialisation estimated to be in FY 2024 onwards, the company added.

Follow and connect with us on , Facebook, Linkedin

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.